LEO reduced BUN and Scr levels and downregulated TNF-α, IL-1, IL-6, IL-8, and kidney injury molecule-1 (KIM-1) expression by inhibiting the ROS-mediated NF-kB signaling pathway in a mouse model of lipopolysaccharide (LPS)-induced renal injury [107]. The gene discussed is TNF; the disease is injury.